Drug Development Trends in Asia/Pacific - Albert Liou

| October 29, 2013

article image
Albert Liou Corporate Vice President and General Manager at PAREXEL, comments on the drug development trends in Asia/Pacific including market growth, patient/hospital care, regulatory landscape and technologies. Liou also highlights which countries to watch in terms of growth and innovation.

Spotlight

Coral Drugs. Pvt. Ltd.

Coral Drugs Pvt. Ltd. manufactures a wide range of high quality pharmaceutical ingredients. At Coral, we value the quality of our products above all else, which is demonstrated by regular audits of our factory as well as compliance with local and international regulatory governing authorities. Apart from our existing product line, Coral's R & D team is looking ahead to create multidimensional therapeutic products. Our purpose is to meet the medical needs of today.

OTHER ARTICLES

5 Pharma Trends and Their Impact on Packaging

Article | February 27, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

Pricing of drugs – at what cost?

Article | February 27, 2020

We go into a doctor’s office and leave with a diagnosis and a prescription. Next we stop by the pharmacy. In Germany, if your insurance is not private, you mostly don’t even know the price of your drug because it’s paid for directly by your insurance. You only notice the 5-10 Euros copay. But how is a drug priced in Germany? And (how) does data play a role in helping pharma secure an attractive price point? Let’s fast forward directly to the launch of a new drug. At the time of launch, the pharmaceutical company has to present patient level evidence of the drug’s added value compared to existing comparative therapies. In the first year, however, the drug’s price can be defined freely by the company.

Read More

How pharma can continue engaging HCPs in a world gripped by COVID-19

Article | April 10, 2020

Medscape is the leading source of clinical news, health information, and point-of-care tools for healthcare professionals. Medscape offers specialists, primary care physicians, and other health professionals the most robust and integrated medical information and educational tools. Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses and other educational programmes for physicians, nurses, and other healthcare professionals. Both Medscape and Medscape Education are part of WebMD Health Corp., an Internet Brands company. Face-to-face interactions between pharma and physicians have essentially ceased overnight during the COVID-19 pandemic, but that doesn’t mean HCPs have stopped looking for new medical information.

Read More

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | April 10, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

Spotlight

Coral Drugs. Pvt. Ltd.

Coral Drugs Pvt. Ltd. manufactures a wide range of high quality pharmaceutical ingredients. At Coral, we value the quality of our products above all else, which is demonstrated by regular audits of our factory as well as compliance with local and international regulatory governing authorities. Apart from our existing product line, Coral's R & D team is looking ahead to create multidimensional therapeutic products. Our purpose is to meet the medical needs of today.

Events